DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Deferoxamine Mesylate is a drug marketed by Dr Reddys, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, and West-ward Pharms Int. and is included in five NDAs.
The generic ingredient in DEFEROXAMINE MESYLATE is deferoxamine mesylate. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the deferoxamine mesylate profile page.
A generic version of DEFEROXAMINE MESYLATE was approved as deferoxamine mesylate by HOSPIRA on March 17th, 2004.
Summary for DEFEROXAMINE MESYLATE
|Finished Product Suppliers / Packagers:||5|
|Raw Ingredient (Bulk) Api Vendors:||69|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for DEFEROXAMINE MESYLATE|
|DailyMed Link:||DEFEROXAMINE MESYLATE at DailyMed|
Recent Clinical Trials for DEFEROXAMINE MESYLATE
Identify potential brand extensions & 505(b)(2) entrants
|Michigan Medicine PKUHSC Joint Institute for Translational & Clinical Research||Phase 2|
|Aditya S. Pandey, MD||Phase 2|
|Beijing Jishuitan Hospital||Phase 1/Phase 2|